SMLR Share Price Performance
Recent SMLR News & Updates
No updates
Semler Scientific, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 04, 2025
- Earnings per share (EPS)
- -1.29
- Gross Margin
- 90.96%
- Net Profit Margin
- -60.69%
- Debt/Equity Ratio
- 59.4%
Semler Scientific, Inc. Competitors
About SMLR
- Founded
- 2007
- Employees
- 79
- CEO
- WebsiteView website
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
U.S. Market Performance
- 7 Days: -0.6%
- 3 Months: 11.8%
- 1 Year: 16.8%
- Year to Date: 7.5%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 4.2%. Meanwhile, the market is actually up 17% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading